|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
7 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Long-lived asset impairment charges | |||||
| Depreciation and amortization | |||||
| Provision for doubtful accounts | |||||
| Deferred income tax provision | |||||
| Non-cash lease expense related to right-of-use assets | |||||
| Non-cash share-based compensation | |||||
| Amortization of debt issuance costs and original issue discount | |||||
| Non-cash interest expense | |||||
| Non-cash interest expense on redeemable preferred stock | |||||
| Loss on extinguishment of debt | |||||
| Loss (gain) on disposal and impairment of assets | |||||
| Loss on lease terminations | |||||
| Loss on disposal and sale of assets | |||||
| Change in fair value of 2L Notes | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of contingent common shares liability | |||||
| Change in fair value of warrant liability and contingent common shares liability | |||||
| Change in fair value of non-designated derivative instrument | |||||
| Changes in: | |||||
| Accounts receivable, net | |||||
| Insurance recovery receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Other non-current liabilities | |||||
| Medicare Accelerated and Advance Payment Program Funds | |||||
| Transaction-related amount due to former owners | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of intangible assets | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from sale of clinics | |||||
| Clinics | |||||
| Home Health service line | |||||
| Total proceeds from sale of clinics | |||||
| Business acquisitions, net of cash acquired | |||||
| Payment of holdback liabilities related to acquisitions | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from long-term debt | |||||
| Proceeds from long-term debt from related parties | |||||
| Proceeds from 2L Notes from related parties | |||||
| Financing transaction costs | |||||
| Deferred financing costs | |||||
| Original issue discount | |||||
| Principal payments on long-term debt | |||||
| Proceeds from issuance of Series A Senior Preferred Stock | |||||
| Proceeds from revolving line of credit | |||||
| Payments on revolving line of credit | |||||
| Equity issuance costs and original issue discount | |||||
| Payment of contingent consideration liabilities | |||||
| Taxes paid on behalf of employees for shares withheld | |||||
| Distribution to non-controlling interest holders | |||||
| Net cash provided by (used in) financing activities | |||||
| Changes in cash and cash equivalents: | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental noncash disclosures: | |||||
| Derivative changes in fair value | |||||
| Purchases of property and equipment in accounts payable | |||||
| Warrant liability recognized upon the closing of the Business Combination | |||||
| Contingent common shares liability recognized upon the closing of the Business Combination | |||||
| Shares issued to Wilco Holdco Series A Preferred stockholders | |||||
| Exchange for related party 2L Notes | |||||
| Senior Secured Term Loan (due February 24, 2028) | |||||
| Delayed Draw Right | |||||
| Total exchange for related party 2L Notes | |||||
| Debt discount on Senior Secured Term Loan | |||||
| Capital contribution from recognition of delayed draw right asset | |||||
| Series A Senior Preferred Stock dividends and redemption value adjustments | |||||
| Other supplemental disclosures: | |||||
| Cash paid for interest | |||||
| Cash received from hedging activities | |||||
| Cash received from taxes, net of payments | |||||
Loading...